Published date: Sep 24 2018

Journal Title: Sudan Journal of Medical Sciences

Issue title: Sudan JMS: Volume 13 (2018), Issue No. 3

Pages: 133-143

DOI: 10.18502/sjms.v13i3.2952

Eltigani M A Alieltigani_ali@yahooo.com

Nahla Mohamed Elhadi

Mohamed B Abdelraheemelfakky@hotmail.com

Rashid A Ellidir

Gada Osmangadoshka68@yahoo.com

Background: Childhood steroid-sensitive nephrotic syndrome (SSNS) usually has a favorable outcome in spite of its relapsing course. The objective of the authors was to study the demographic and clinical characteristics, outcome and risk factors for relapses in children with SSNS at a single center in Khartoum, Sudan.

Material and Methods: In this cross-sectional, facility-based study, the authors retrospectively reviewed all the records of children with SSNS, followed at the Pediatric Renal Unit, Soba University Hospital, Khartoum between 2001 and 2014. SSRNS was defined as the remission of proteinuria within 4–6 weeks of corticosteroids. Relapse is the
recurrence of proteinuria after remission; frequent if ≥ 2 within initial six months or ≥ 4 within one year, and steroid dependence if 2 during therapy or within 14 days after stopping it.

Results: 330 children (males 220; 66.7%) with SSNS were studied with a mean age of 5.2 ± 3.5 years of whom 42.4% aged 1–5 years. At the presentation, hypertension was detected in 31.8% and hematuria in 19.1%. Serum cholesterol was elevated in all patients (mean 347.34 ± 117.87 mg/dl) and serum creatinine in 7.27% (mean 1.4 ± 0.35 mg/dl). Renal histology showed mesangioproliferative glomerulonephritis (MesPGN) in 57.5%, minimal change disease (MCD) in 35.5%, and focal segmental glomerulosclerosis (FSGS) and IgM nephropathy in 3.5% each. During the course of the illness, 10.3% achieved long-term remission, 89.7% relapsed— of whom 52.3% had frequent relapsing/steroid-dependent (FR/SD) course and 37.7% had infrequent relapses. Risk of frequent relapses were age of onset and low/moderate socioeconomic status (P = 0.015 and 0.019, respectively). Infections
were recorded in 71.8%, but not significantly associated with the risk of frequent relapses (P > 0.05).

Conclusions: The majority children with SSNS at this single center in Khartoum had a relapsing course with the majority being FR or SD. Predictors of frequent relapses were young age at onset and low socioeconomic status.

[1] International Study of Kidney Disease in Children. (1981). The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisolone: A report of the International Study of Kidney Disease in Children. The Journal of Pediatrics, vol. 98, pp. 561–564.

[2] Bhimma, R., Coovadia, H. M., and Adhikari, M. (1997). Nephrotic syndrome in South African children: Changing perspectives over 20 years. Pediatric Nephrology, vol. 11,pp. 429–434.

[3] Tarshish, P., Tobin, J. N., Bernstein, J., et al. (1997). Prognostic significance of the early course of minimal change nephrotic syndrome: Report of International Study of Kidney Disease in Children. Journal of the American Society of Nephrology, vol. 8, pp. 769–776.

[4] Hodson, E. M., Willis, N. S., and Craig, J. C. (2008). Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst. Rev, vol. 1, CD002290. DOI:10.1002/14651858. CD002290. pub 3‘.

[5] Kabuki, N., Okugawa, T., Hayakawa, H., et al. (1998). Influence of age of onset on the outcome of steroid sensitive nephrotic syndrome. Pediatric Nephrology, vol. 12,pp. 467–470.

[6] Vivarelli, M., Moscaritolo, E., Tsalkidis, A., et al. (2010). Time to initial response to steroids is a major prognostic factor in idiopathic nephrotic syndrome. The Journal of Pediatrics, vol. 156, pp. 965–971.

[7] Arbeitsgemeinschaft fur Padiatrische Nephrologie. (1988). Short versus standard prednisolone therapy for initial treatment of idiopathic nephrotic syndrome in children. Lancet, vol. 1, pp. 380–383.

[8] Abeyagunawardena, A. S. and Trompeter, R. S. (2008). Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomized controlled trial. Archives of Disease in Childhood, vol. 93, pp. 226–228.

[9] Gulati, A., Sinha, A., Sreenivas, V., et al. (2011). Daily corticosteroids reduce infectionassociated relapses in frequently relapsing nephrotic syndrome: A randomized controlled trial. Clinical Journal of the American Society of Nephrology, vol. 6, pp. 163–171.

[10] Hiraoka, M., Tsukahara, H., Matsubara, K., et al. (2003). A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children. American Journal of Kidney Diseases, vol. 41, p. 1155.

[11] Alwadhi, R. K., Mathew, J. L., and Rath, B. (2004). Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infections. Journal of Pediatrics and Child Health, vol. 40, pp. 28–32.

[12] Kerlin, B. A., Blatt, N. B., Fuh, B., et al. (2009). Epidemiology and risk factors for thrombo-embolic complications of childhood nephrotic syndrome: A Midwest Pediatric Nephrology Consortium (MWPNC) study. The Journal of Pediatrics, vol. 155, pp. 105–110.

[13] Vande Walle, J. G., Donckerwolcke, R. A., Van Isselt, J. W., et al. (1995). Volume depletion in children with early relapse of minimal change nephrosis with or without hypovolaemic symptoms. Lancet, vol. 346, p. 148.

[14] Fakhouri, F., Bocquet, N., Taupin, P., et al. (2003). Steroid sensitive nephrotic syndrome: From childhood to adulthood. American Journal of Kidney Diseases, vol. 41, pp. 550–557.

[15] Report of Workshop by the British Association for Pediatric Nephrology and Research Unit, Royal College of Physicians. (1994). Consensus statement on management and audit potential for steroid responsive nephrotic syndrome. Archives of Disease in Childhood, vol. 70, pp. 151–157.

[16] Kher, K. K., Schnaper, H. W., and Makker, S. P. (2007). Clinical Pediatric Nephrology (second edition). UK: Informa; Health care.

[17] International Study of Kidney Disease in Children. (1978). Nephrotic syndrome in children. Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. A report of the international study of kidney disease in children. Kidney International, vol. 13, pp. 159–165.

[18] Schwartz, G. J., Muñoz, A., Schneider, M. F., et al. (2009). New equations to estimate GFR in children with CKD. Journal of the American Society of Nephrology, vol. 20, pp. 629–637.

[19] National Kidney Foundation. (2008). K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. American Journal of Kidney Diseases, vol. 39, S1.

[20] U.S. Department of Health and Human Services. National Institutes of Health National Heart, Lung and Blood Institute. The Fourth Report on the Diagnosis, evaluation, and Treatment of High Blood Pressure in Children and Adolescents. NIH Publication No. 05-5267 (originally printed on September 1996, Revised May 2005).

[21] Grossfeld, G. D. and Carroll, P. R. (1998). Evaluation of asymptomatic microscopic hematuria. Urologic Clinics of North America, vol. 25, pp. 661–676.

[22] Olowu, W. A., Adelusola, K. A., and Adefehinti, O. (2010). Childhood idiopathic steroid resistant nephrotic syndrome in Southwestern Nigeria. Saudi Journal of Kidney Disease and Transplantation, vol. 21, pp. 979–990.

[23] International Study of Kidney Disease in Children. (1997). Nephrotic syndrome in children: Prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney International, vol. 13, pp. 159–165.

[24] Mishra, O. P., Abhinay, A., Mishra, R. N., et al. (2013). Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome? Journal of Tropical Pediatrics, vol. 59, pp. 343–349.

[25] Koskimies, O., Vilska, J., Rapola, J., et al. (1982). Long term outcome of primary nephrotic syndrome. Archives of Disease in Childhood, vol. 57, pp. 544–548.

[26] Noer, M. S. (2000). Predictors of relapse in steroid-sensitive nephrotic syndrome. The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 36, pp. 1313–1320.

[27] Lewis, M. A., Davis, N., Baildom, E. M., et al. (1989). Nephrotic syndrome: From toddlers to twenties. Lancet, vol. 86, pp. 255–259.

[28] Kabuki, N., Okugawa, T., Hayakawa, H., et al. (1998). Influence of age at onset on the outcome of steroid-responsive nephrotic syndrome. Pediatric Nephrology, vol.12, pp. 467–470.

[29] Moorani, K. N. (2011). Infections are common a cause of relapse in children with Nephrotic syndrome. Pakistan Pediatric Journal, vol. 35, pp. 213–219.

[30] MacDonald, N., Wolfish, N., Mclaine, P., et al. (1986). Role of respiratory viruses in exacerbations of primary nephrotic syndrome. Journal of Pediatrics, vol. 108, pp. 378–382.

[31] Takahashi, S., Wada, N., Murakami, H., et al. (2007). Triggers of relapse in steroiddependent and frequently relapsing nephrotic syndrome. Pediatric Nephrology, vol.22, pp. 232–236.

[32] Afroz, S., Khan Hossain, M. A., Roy, K. D., et al. (2010). Urinary Tract Infection (UTI) is associated with higher rate of relapse in children with nephrotic syndrome. DS (Child) H J, vol. 26, p. 826.